JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,021,326 | +6.5% | 6,351,322 | +25.5% | 0.01% | +20.0% |
| Q2 2023 | $60,095,389 | -51.7% | 5,062,796 | -50.8% | 0.01% | -16.7% |
| Q1 2023 | $124,403,584 | +68.5% | 10,281,288 | +83.4% | 0.01% | -14.3% |
| Q4 2022 | $73,829,176 | -12.7% | 5,605,860 | -10.3% | 0.01% | -22.2% |
| Q3 2022 | $84,589,000 | +18.9% | 6,247,392 | +7.2% | 0.01% | +28.6% |
| Q2 2022 | $71,132,000 | -12.6% | 5,825,704 | +2.6% | 0.01% | 0.0% |
| Q1 2022 | $81,407,000 | -17.3% | 5,676,926 | +13.7% | 0.01% | 0.0% |
| Q4 2021 | $98,480,000 | +25.9% | 4,991,402 | +38.1% | 0.01% | +16.7% |
| Q3 2021 | $78,202,000 | +70.0% | 3,615,431 | +96.1% | 0.01% | +50.0% |
| Q2 2021 | $45,997,000 | – | 1,843,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |